VCP Scanner
Stock Screener
Filter stocks with fundamental & technical criteria
Technical Scanner
RSI, Moving averages & volume momentum signals
Market Themes
Curated industry baskets & thematic leaders
Earnings Hub
Calendar, EPS surprise stats & earnings transcripts
Market News
Real-time market intelligence & AI overviews
Insider Buying
SEC Form 4 corporate insider purchases
Minervini — VCPContraction bases in Stage 2 uptrends
Minervini — Trend TemplateFull 8-rule Stage 2 screen
O'Neil — Cup with HandleBase breakouts with RS leadership
O'Neil — CANSLIM LeadersGrowth leaders with RS ≥ 85
Qullamaggie — High Tight FlagsPower plays after a large advance
Qullamaggie — Momentum Leaders1/3/6-month strength leaders
Livermore — Pivotal PointsMulti-touch resistance breakouts
View All Playbooks...
Breakouts
FAANG & Tech
AAPL vs MSFTNVDA vs AMDGOOGL vs META
Cloud & Cyber
CRM vs NOWCRWD vs PANWSNOW vs DDOG
Consumer & Auto
TSLA vs FAMZN vs WMTNFLX vs DIS
Finance & Crypto
JPM vs BACV vs MACOIN vs MSTR
Index & ETFs
SPY vs QQQVTI vs VOOSPY vs IWM
Compare Any Stocks...
DCF ValuationCalculate intrinsic value of US stocks
Market ValuationBuffett indicator, CAPE & macro gauges
Total ReturnSee dividends + price return history
DCA CalculatorSimulate recurring buys & compounding
VisualizeInteractive multi-year financial charts
Watchlist
Breakouts
WatchlistPricing
Ctrl K
Pricing
PTGX
← Back to Screener
VCP ScannerFree US Stock Screener & Financial Analysis

Find stocks. Analyze deeply. Research with clarity.

Data updated daily

Product

  • Screener
  • Themes
  • Valuation
  • Total Return
  • DCA Calculator
  • Pricing
  • News
  • Earnings

Resources

  • Market Valuation
  • Compare
  • Insider Activity
  • Methodology
  • How It Works
  • Glossary
  • Learn

Get Ideas

Get weekly market insights — free

© 2026 VCP Scanner
AboutPrivacyTermsRefund Policy
Not financial advice. Do your own research.
ScreenerBreakoutsCompareWatchlist
PTGXProtagonist Therapeutics, Inc.
$140.06$9.0B
Overview & Tools
OverviewChart Terminal ↗Visualize
Valuation & Forecasts
Valuation ModelsEstimatesDCF Model
Price & Analyst Data
Analyst TargetsPrice History
Financial Statements
Income StatementBalance SheetCash FlowRatios & Margins
Performance
P/E HistoryRevenue HistoryEarnings HistoryDividend HistoryTotal Return
Discovery & Screens
Live BreakoutsStock ScreenerOwnership
HomeStocksPTGXPrice History

PTGX logoProtagonist Therapeutics, Inc. (PTGX) Stock Price History

Historical prices from 2016 to 2026

$144.98+1.98  (+1.38%)close Sep 21
Returns
1M
-6.1%
3M
+26.0%
YTD
+66.3%
1Y
+124.7%
3Y
+104.4%
5Y
+56.8%
ATH$160.81Aug 2026-9.8%
ATL$4.47Dec 2019pre-split
Avg Vol (50D)555K/ day
52-Week Range$61.95 — $160.81
LowCurrent: $144.98High

Loading 10-year price history...

PTGX Historical Performance

1 YearTotal Return
+124.7%
Price: +124.7%
3 YearsTotal Return
+753.8%
CAGR: +104.4%
Price: +753.8%
5 YearsTotal Return
+847.0%
CAGR: +56.8%
Price: +847.0%
YTD
+66.3%

PTGX Annual Returns

Year-by-year price performance · 2016–2026

Best+190.9%2020
Worst-69.1%2022
Up years8/11
2016+87.9%
2017-1.8%
2018-68.2%
2019+2.3%
2020+190.9%
2021+74.5%
2022-69.1%
2023+112.7%
2024+64.8%
2025+124.1%
2026+56.7%
2016 annual price return
+87.9%
2017 annual price return
-1.8%
2018 annual price return
-68.2%
2019 annual price return
+2.3%
2020 annual price return
+190.9%
2021 annual price return
+74.5%
2022 annual price return
-69.1%
2023 annual price return
+112.7%
2024 annual price return
+64.8%
2025 annual price return
+124.1%
2026 annual price return
+56.7%
LessMore
Alpha vs S&P 500
1Y+108.7%
3Y+79.4%
5Y+49.4%

Price returns only.

Download Historical Data

2,541 records • Includes OHLCV + Technical Indicators (MA50, MA200, RSI)

Free sign in required to download data

PTGX Stock Price Trajectory (2016–2026)

As of October 3, 2026, Protagonist Therapeutics, Inc. (PTGX) trades at $144.98, representing a +124.7% return over the past year. The stock has delivered a +847.0% total return over five years (+56.8% CAGR), reflecting significant long-term value creation.

The stock reached its all-time high of $160.81 on August 19, 2026. From this peak, PTGX has corrected -9.8%, currently trading 33% above its 200-day moving average, indicating continued institutional support.

When compared to Healthcare sector peers IMVT (+138.5% 1Y), KYMR (+130.7% 1Y), and PRTA (+2.7% 1Y), PTGX has underperformed the peer group average. Compare PTGX vs IMVT →

PTGX Historical Price Data · from 2016

Rows 1–50 of 2,541
Date Open High Low Close Volume Change %
2026-09-21143.95145.37143.53144.98725K+1.38%
2026-09-18143.65144.58140.44143.001.78M-0.49%
2026-09-17144.72146.50142.31143.70559K+0.60%
2026-09-16144.19146.19140.88142.84507K-0.39%
2026-09-15147.48147.48142.21143.40605K-2.96%
2026-09-14149.92150.08146.86147.78598K-0.27%
2026-09-11147.18150.48145.91148.18476K+2.08%
2026-09-10143.29146.40142.00145.16538K+0.05%
2026-09-09145.78151.27144.38145.09530K-0.58%
2026-09-08142.35147.24142.35145.94635K+0.15%
2026-09-04146.47147.99144.24145.72501K-2.07%
2026-09-03146.68149.49144.00148.80354K+1.86%
2026-09-02148.00149.90144.61146.08561K-0.28%
2026-09-01148.13150.35144.73146.49534K-0.85%
2026-08-31143.26149.29142.72147.75567K+2.37%
2026-08-28147.73147.73142.44144.33500K-3.46%
2026-08-27150.35151.68147.11149.50381K-1.32%
2026-08-26150.36152.07147.69151.50335K+0.60%
2026-08-25155.84157.98150.09150.59665K-2.67%
2026-08-24154.32158.08149.94154.72483K+0.26%
2026-08-21152.10154.95150.82154.32403K+2.41%
2026-08-20152.45155.25148.28150.69519K-2.74%
2026-08-19160.81160.81154.22154.94786K-1.53%
2026-08-18157.96160.00156.81157.34472K-0.81%
2026-08-17155.11158.95153.60158.62507K+2.27%
2026-08-14150.23155.53149.17155.10426K+2.43%
2026-08-13153.15154.99150.92151.42445K-0.39%
2026-08-12148.21152.70147.33152.01417K+2.51%
2026-08-11151.88151.88147.37148.29307K-1.14%
2026-08-10149.31151.60147.40150.00546K+2.83%
2026-08-07146.18147.32144.44145.87321K-0.21%
2026-08-06145.01148.00139.95146.18838K+6.45%
2026-08-05137.49138.08135.39137.32431K+1.11%
2026-08-04133.02138.05132.26135.81635K+2.67%
2026-08-03135.78135.98131.68132.28451K-3.19%
2026-07-31138.36138.37131.69136.64549K-1.44%
2026-07-30131.77138.95130.63138.64556K+4.24%
2026-07-29136.90137.43132.72133.00596K-2.81%
2026-07-28136.69137.00133.20136.84282K+0.94%
2026-07-27136.11139.92135.43135.56417K-0.40%
2026-07-24136.11137.20133.78136.11298K+0.50%
2026-07-23133.79137.32132.00135.43606K-0.01%
2026-07-22139.45139.45134.42135.44710K-2.08%
2026-07-21133.34139.72131.05138.31581K+3.01%
2026-07-20141.79143.29133.64134.27763K-4.71%
2026-07-17131.37141.08131.37140.91519K+6.73%
2026-07-16135.21136.56131.35132.02602K-2.54%
2026-07-15128.00139.22126.97135.46836K+3.19%
2026-07-14131.89131.95128.68131.27565K+1.06%
2026-07-13130.05131.36125.32129.89541K-1.16%
…
Consensus & Technical Research Suite
Open PTGX Terminal

PTGX Chart Terminal

WASM

Live VCP patterns, Cup & Handle overlays, support/resistance, and AI trade plans.

Launch Terminal

Live Breakouts Feed

LIVE

High-probability breakout stocks crossing their pivot across 5 pattern engines.

Explore Setups

Intrinsic Valuation

DCF models, multiple analysis, and analyst estimates.

Check Valuation

Historical Returns

10-year return with dividends reinvested.

Calculate

Peer Comparison

Compare growth, multiples, and margins vs sector.

Compare

PTGX — Frequently Asked Questions

Quick answers to the most common questions about buying PTGX stock.

How has PTGX stock performed recently?

PTGX returned +124.7% over the past year, beating its 5-year annualized CAGR of +56.8%. The stock trades above its 200-day moving average, confirming the uptrend.

What is PTGX's all-time high price?

Protagonist Therapeutics, Inc. reached $160.81 on 2026-08-19. The 52-week high is $160.81. Current 1-year return of +124.7% places the stock closer to historical peaks.

Where can I download PTGX historical price data?

This page provides PTGX daily OHLCV data with 50-day MA, 200-day MA, and RSI indicators. Data spans 2016-2026, downloadable in CSV format.

426 data points · sampled from 2,550